However, an accurate serum marker for screening and early diagnosis would certainly be useful for those patients that may experience an increased risk of developing EC, such as those with severe obesity and diabetes, Lynch syndrome, PTEN gene defects or breast cancer women on Tamoxifen. This evidence concerns the gene PTEN and Obesity.